Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
3.150
-0.070 (-2.17%)
Dec 20, 2024, 4:00 PM EST - Market closed
Acelyrin Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 115.94 | 63.18 | 13.55 | 3.56 |
| Research & Development | 257.4 | 225.23 | 55.63 | 38.23 |
| Operating Expenses | 373.34 | 288.41 | 69.18 | 41.79 |
| Operating Income | -373.34 | -288.41 | -69.18 | -41.79 |
| Interest & Investment Income | 35.2 | 30.56 | 4.05 | - |
| Currency Exchange Gain (Loss) | -0.4 | -0.4 | -0.1 | - |
| Other Non Operating Income (Expenses) | -10.09 | 10.27 | 0.46 | -0.05 |
| EBT Excluding Unusual Items | -348.63 | -247.98 | -64.77 | -41.84 |
| Merger & Restructuring Charges | 38.28 | -10 | - | - |
| Other Unusual Items | 29.4 | -0.6 | - | - |
| Pretax Income | -264.41 | -381.64 | -64.77 | -41.84 |
| Net Income | -264.41 | -381.64 | -64.77 | -41.84 |
| Net Income to Common | -264.41 | -381.64 | -64.77 | -41.84 |
| Shares Outstanding (Basic) | 99 | 70 | 2 | 1 |
| Shares Outstanding (Diluted) | 99 | 70 | 2 | 1 |
| Shares Change (YoY) | 112.80% | 4410.31% | 126.58% | - |
| EPS (Basic) | -2.68 | -5.43 | -41.59 | -60.87 |
| EPS (Diluted) | -2.68 | -5.43 | -41.59 | -60.87 |
| Free Cash Flow | -257.23 | -172 | -61.52 | -4.98 |
| Free Cash Flow Per Share | -2.61 | -2.45 | -39.50 | -7.24 |
| EBITDA | -373.01 | -288.29 | - | - |
| D&A For EBITDA | 0.33 | 0.12 | - | - |
| EBIT | -373.34 | -288.41 | -69.18 | -41.79 |
Source: S&P Capital IQ. Standard template.
Financial Sources.